Practical recommendations and perspectives on cardiac screening for healthy pediatric athletes

Current Sports Medicine Reports

Volumn 10, Issue 2, 2011, Pages 90-98

  Behera, Sarina K ^a   Pattnaik, Tanaya ^b   Luke, Anthony ^b  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA RUPTURE; AORTA STENOSIS; ATHLETE; CARDIOLOGIST; CARDIOVASCULAR SYSTEM EXAMINATION; CORONARY ARTERY ANOMALY; DYSPNEA; ELECTROCARDIOGRAM; EXERCISE; FAMILY HISTORY; HEART; HEART DISEASE; HEART MURMUR; HEART PALPITATION; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MARFAN SYNDROME; MEDICAL HISTORY; PHYSICAL EXAMINATION; PHYSICIAN; REVIEW; SCREENING TEST; SPORTS MEDICINE; SUDDEN DEATH; SYNCOPE; THORAX PAIN; WOLFF PARKINSON WHITE SYNDROME;

ATHLETES; CARDIOMEGALY; CHILD; DEATH, SUDDEN, CARDIAC; DYSPNEA; ELECTROCARDIOGRAPHY; HUMANS; MASS SCREENING; MEDICAL HISTORY TAKING; PHYSICAL ENDURANCE; PHYSICAL EXAMINATION; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; SPORTS MEDICINE; SYNCOPE;

EID: 80051902208     PISSN: 1537890X     EISSN: 15378918     Source Type: Journal    
DOI: 10.1249/JSR.0b013e3182141c1e     Document Type: Review

References (51)

1. American Academy of Pediatrics. PPE Preparticipation Physical Evaluation, Fourth Edition. American Academy of Pediatrics 2010.
2. Baggish AL, Hutter AM Jr, Wang F, et al. Cardiovascular screening in college athletes with and without electrocardiography: a cross-sectional study. Ann. Intern. Med. 2010; 152:269-75.
3. Basavarajaiah S, Boraita A, Whyte G, et al. Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 2008; 51:2256-62. (Pubitemid 351754996)
4. Basso C, Maron BJ, Corrado D, Thiene G. Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J. Am. Coll. Cardiol. 2000; 35:1493-501. (Pubitemid 30307492)
5. Carek PJ, Futrell M, Hueston WJ. The preparticipation physical examination history: who has the correct answers? Clin. J. Sport Med. 1999; 9:124-8.
6. Colman N, Bakker A, Linzer M, et al. Value of history-taking in syncope patients: in whom to suspect long QT syndrome? Europace. 2009; 11:937-43.
7. Corrado D, Basso C, Pavei A, et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a pre-participation screening program. JAMA. 2006; 296:1593-601. (Pubitemid 44515020)
8. Corrado D, Pelliccia A, Heidbuchel H, et al. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur. Heart J. 2010; 31:243-59.
9. D'Andrea A, Riegler L, Cocchia R, et al. Left atrial volume index in highly trained athletes. Am. Heart J. 2010; 159:1155-61.
10. Danduran MJ, Earing MG, Sheridan DC, et al. Chest pain: characteristics of children/adolescents. Pediatr. Cardiol. 2008; 29:775-81.
11. Drezner JA, Chun JS, Harmon KG, Derminer L. Survival trends in the United States following exercise-related sudden cardiac arrest in the youth: 2000-2006. Heart Rhythm. 2008; 5:794-9.
12. Evangelista JA, Parsons M, Renneburg AK. Chest pain in children: diagnosis through history and physical examination. J. Pediatr. Health Care. 2000; 14:3-8.
13. Fitzsimmons PJ, McWhirter PD, Peterson DW, Kruyer WB. The natural history of Wolff Parkinson-White syndrome in 228 military aviators: a long-term follow-up of 22 years. Am. Heart J. 2001; 142: 530-6. (Pubitemid 32807682)
14. Fuller CM. Cost effectiveness analysis of screening of high school athletes for risk of sudden cardiac death. Med. Sci. Sports Exerc. 2000; 32:887-90. (Pubitemid 30230667)
15. Graham TP Jr, Driscoll DJ, Gersony WM, et al. Task Force 2: congenital heart disease. J. Am. Coll. Cardiol. 2005; 45:1326-33. (Pubitemid 40523163)
16. Hancock EW, Deal BJ, Mirvis DM, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J. Am. Coll. Cardiol. 2009; 53: 992-1002.
17. Heidbuchel H, Panhuyzen-Goedkoop N, Corrado D, et al. Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions, part I: supraventricular arrhythmias and pacemakers. Eur. J. Car-diovasc. Prev. Rehabil. 2006; 13:475-84. (Pubitemid 44164254)
18. Kane DA, Fulton DR, Saleeb S, et al. Needles in hay: chest pain as the presenting symptom in children with serious underlying cardiac pathology. Congenit. Heart Dis. 2010; 5:366-73.
19. Klein GJ, Bashore TM, Sellers TD, et al. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N. Engl. J. Med. 1979; 301:1080-5. (Pubitemid 10217084)
20. La Gerche A, Taylor AJ, Prior DL. Athlete's heart: the potential for multimodality imaging to address the critical remaining questions. JACC Cardiovasc. Imaging. 2009; 2:350-63.
21. Lawless CE, Best TM. Electrocardiograms in athletes: interpretation and diagnostic accuracy. Med. Sci. Sports Exerc. 2008; 40:787-98.
22. Le VV, Wheeler MT, Mandic S, et al. Addition of the electrocardiogram to the preparticipation examination of college athletes. Clin. J. Sport Med. 2010; 20:98-105.
23. Maraj S, Figueredo VM, Lynn Morris D. Cocaine and the heart. Clin. Cardiol. 2010; 33:264-9.
24. Marcus F, Towbin JA, Zareba W, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a multidisciplinary study: design and protocol. Circulation. 2003; 107:2975-8. (Pubitemid 36736642)
25. Maron BJ. National electrocardiography screening for competitive athletes: feasible in the United States? Ann. Intern. Med. 2010; 152: 324-6.
26. Maron BJ. Structural features of the athlete heart as defined by echo-cardiography. J. Am. Coll. Cardiol. 1986; 7:190-203. (Pubitemid 16132478)
27. Maron BJ. Hypertrophic cardiomyopathy and other causes of sudden cardiac death in young competitive athletes, with considerations for preparticipation screening and criteria for disqualification. Cardiol Clin. 2007; 25:399-414. (Pubitemid 47603215)
28. Maron BJ, Araujo CG, Thompson PD, et al. Recommendations for pre-participation screening and the assessment of cardiovascular disease in masters athletes: an advisory for healthcare professionals from the working groups of the World Heart Federation, the International Federation of Sports Medicine, and the American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation. 2001; 103:327-34. (Pubitemid 32097978)
29. Maron BJ, Carney KP, Lever HM, et al. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyop-athy. J. Am. Coll. Cardiol. 2003; 41:974-80. (Pubitemid 36315540)
30. Maron BJ, Doerer JJ, Haas TS, et al. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009; 119:1085-92.
31. Maron BJ, Haas TS, Doerer JJ, et al. Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies. Am. J. Cardiol. 2009; 104:276-80.
32. Maron BJ, Mitten MJ, Quandt EF, Zipes DP. Competitive athletes with cardiovascular disease V the case of Nicholas Knapp. N. Engl. J. Med. 1998; 339:1632-5. (Pubitemid 28536141)
33. Maron BJ, Thompson PD, Ackerman MJ, et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation. 2007; 115:1643-55. (Pubitemid 46648650)
34. Massin MM, Benatar A, Rondia G. Epidemiology and outcome of tachy-arrhythmias in tertiary pediatric cardiac centers. Cardiology. 2008; 111: 191-6.
35. O'Connor FG, Meyering CD, Patel R, Oriscello RP. Hypertension, athletes, and the sports physician: implications of JNC VII, the Fourth Report, and the 36th Bethesda Conference Guidelines. Curr. Sports Med. Rep. 2007; 6:80-4. (Pubitemid 46623781)
36. Papadakis M, Basavarajaiah S, Rawlins J, et al. Prevalence and significance of T-wave inversions in predominantly Caucasian adolescent athletes. Eur. Heart J. 2009; 30:1728-35.
37. Pelliccia A. The preparticipation cardiovascular screening of competitive athletes: is it time to change the customary clinical practice? Eur. Heart J. 2007; 28:2703-5. (Pubitemid 350135543)
38. Pelliccia A, Corrado D. Can electrocardiographic screening prevent sudden death in athletes? Yes. BMJ. 2010; 341:c4923.
39. Pelliccia A, Corrado D. Electrocardiography and preparticipation screening of competitive high school athletes. Ann. Intern. Med. 2010; 153:132.
40. Pelliccia A, Di Paolo FM, Corrado D, et al. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes. Eur. Heart J. 2006; 27:2196-200. (Pubitemid 44418944)
41. Pelliccia A, Di Paolo FM, Maron BJ. The athlete's heart: remodeling, electrocardiogram and preparticipation screening. Cardiol. Rev. 2002; 10:85-90. (Pubitemid 34246656)
42. Pelliccia A, Di Paolo FM, Quattrini FM, et al. Outcomes in athletes with marked ECG repolarization abnormalities. N. Engl. J. Med. 2008; 358: 152-61.
43. Phillips B. The JNC 7 hypertension guidelines. JAMA. 2003; 290: 1314.
44. Pluim BM, Zwinderman AH, van der Laarse A, van der Wall EE. The athlete's heart. A meta-analysis of cardiac structure and function. Circulation. 2000; 101:336-44. (Pubitemid 30054163)
45. Sharma S, Maron BJ, Whyte G, et al. Physiologic limits of left ventricular hypertrophy in elite junior athletes: relevance to differential diagnosis of athlete's heart and hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 2002; 40:1431-6. (Pubitemid 35192868)
46. Singh A, Silberbach M. Consultation with the specialist: cardiovascular preparticipation sports screening. Pediatr. Rev. 2006; 27:418-24. (Pubitemid 46495878)
47. Stout M. The Marfan syndrome: implications for athletes and their echo-cardiographic assessment. Echocardiography. 2009; 26:1075-81.
48. Vanberg P, Atar D. Androgenic anabolic steroid abuse and the cardiovascular system. Handb. Exp. Pharmacol. 2010; 195:411-57.
49. Vianna CB, Gonzalez MM, Dallan LA, et al. Anomalous coronary artery causing transmural ischaemia and ventricular tachycardia in a high school athlete. Resuscitation. 2007; 74:183-6. (Pubitemid 46891665)
50. Walsh CA. Syncope and sudden death in the adolescent. Adolesc. Med. 2001; 12:105-32.
51. Wheeler MT, Heidenreich PA, Froelicher VF, et al. Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes. Ann. Intern. Med. 2010; 152:276-86.